Lots More Information

Related Articles

Sources

  • Guyton and Hall. Textbook of Medical Physiology, 9th Ed. p 895.
  • http://www.who.int/mediacentre/factsheets/fs286/en/
  • Lithgow, D.M., Politzer, W.M. (1977). Vitamin A in the treatment of menorrhagia. S. Afr Med J, 51:191-193.
  • Mills, J.L. (1997). Vitamin A and birth defects. Am J Obstet Gynecol, 177(1):31-6.
  • Age-Related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8. Arch Ophthalmol, 119(10):1417-36.
  • Johnson, K.A. (2002). Vitamin nutrition in older adults. Clin Geriatr Med, 18(4):773-99.
  • Rengstorff, R.H., et al. (1988). Topical antioxidant treatment for dry-eye disorders and contact lens-related complications. Afro-Asian J Ophthalmol, 7:81-83.
  • Melhus, H. (1998). Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med , 129(10):770-8.
  • Schoenen J, et al. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998; 50: 466,470.
  • Natural and Alternative TreatmentsTM encyclopedia. www.consumerlab.com
  • Murray, M. (1996). Encyclopedia of Nutritional Supplements. New York, NY: Three Rivers Press.
  • Pelton, R., Lavalle, J., Hawkins, E., Krinsky, E. (1999). Drug-Induced Nutrient Depletion Handbook 1999-2000. Hudson, OH: Lexi-Comp, Inc.
  • Wei, E.K. (2005). Plasma vitamin B-6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst, 97(9):684-92.
  • Kune, G. (2006). Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B-6, B-12, C, E, selenium, and lycopene. Nutr Cancer, 56(1):11-21.
  • Matsubara, K. (2003). Vitamin B-6-mediated suppression of colon tumorigenesis, cell proliferation and angiogenesis (review). J Nutr Biochem,14(5):246-50.
  • Proctor, M.L., Murphy, P.A. (2002). Herbal dietary therapies for primary and secondary dysmenorrhoea (Cochrane Review). The Cochrane Library, Issue 2. Oxford: Update Software.
  • Hvas, A.M., Juul, S., Bech, P., et al. (2004). Vitamin B-6 level is associated with symptoms of depression. Psychother Psychosom, 73.(6):340-343.
  • Kemper, K.J. (2007). Complementary and alternative medicine therapies to promote healthy moods. Pediatr Clin North Am, 54(6):901-26;x.
  • Miodownik, C. (2003). Vitamin B-6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders. Harefuah, 142(8-9):592-6, 647.
  • Miodownik, C. (2006). Vitamin B-6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study. Clin Neuropharmacol, 29(2):68-72.
  • Holm, G. (2003). Carpal tunnel syndrome: Current theory, treatment, and the use of B-6. J Am Acad Nurse Pract, 15(1):18-22.
  • Rattan, V. (1994). Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers. Urol Res, 22(3):161-5.
  • Assimos, D.G. (2000). Role of diet in the therapy of urolithiasis. Urol Clin North Am, 27(2):255-68.
  • Mousain-Bosc, M. (2006). Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B-6. II. Pervasive developmental disorder-autism. Magnes Res,19(1):53-62.
  • Cameron, E. (1976). Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA,73(10):3685-9.
  • Guyton and Hall. Textbook of Medical Physiology 9th Ed. Pages 898.
  • Ting, H.H. (1996). Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest, 97(1):22-8.
  • Taddei, S. (1998). Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation, 97(22):2222-9.
  • Erbs, S. (2003). Improvement of peripheral endothelial dysfunction by acute vitamin C application: Different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J, 146(2):280-5.
  • Falloon, W. (2007). Life Extension, p. 7-10.
  • Wright, M.E., Lawson, K.A., Weinstein SJ, et al. (2006). Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the alpha-tocopherol, beta-carotene cancer prevention study. Am J Clin Nutr, 84(5):1200-7.
  • Traber, M.G. (2006). How much Vitamin E?... Just enough! Am J Clin Nutr, 84(5):959-60.
  • Maras, J.E., Bermudex, O.I., Qiao, N., et al. (2004). Intake of alpha-tocopherol is limited among U.S. adults. J AM Diet Assoc, 104(4):567-75.
  • Plaza, S.M., Lamson, D.W. (2005). Vitamin K-2 in bone metabolism and osteoporosis. Alternative Medicine Rev, 10(1):24-35.
  • Askim, M. (2001). Vitamin K in the Norwegian diet and osteoporosis. Tidsskr Nor. Laedegoren, 121 (22):2614-6.
  • Okano, T. (2005). Vitamin D, K and bone mineral density. Clin Calcium, 15(9):1489-94.
  • Kaneki, M. (2005). Vitamin K-2 as a protector of bone health and beyond. Clin Calcium, 15(4):605-10.
  • Kishimoto, H. (2004). Vitamin K and bone quality. Clin Calcium, 14(4):621-6.
  • Iwamoto, J., Takeda, T., Ichimura, S. (2003). Combined treatment with vitamin K-2 and bisphosphonate in postmenopausal women with osteoporosis. Yonsei Med J, 30;44(5):751-6.
  • Schurgers, L.J., Teunissen, K.J., Knapen, M.H., et al. (2005). Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: Undercarboxylated matrix Gla protein as a marker for vascular calcification. Arterioscler Thronb Vasc Biol, 25(8):1629-33.
  • Geleijnse, J.M., Vermeer, C., Grobbee, D.E., et al. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr, 134(11):3100-5.